WuXi Biologics (Cayman) Inc. (HKG:2269)
31.44
-0.92 (-2.84%)
Mar 30, 2026, 2:25 PM HKT
WuXi Biologics Employees
WuXi Biologics had 13,252 employees as of December 31, 2025. The number of employees increased by 677 or 5.38% compared to the previous year.
Employees
13,252
Change
677
Growth
5.38%
Revenue / Employee
1.83M HKD
Profits / Employee
412.17K HKD
Market Cap
133.89B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13,252 | 677 | 5.38% |
| Jun 30, 2025 | 12,552 | - | - |
| Dec 31, 2024 | 12,575 | -165 | -1.30% |
| Dec 31, 2023 | 12,740 | 367 | 2.97% |
| Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
| Dec 31, 2021 | 9,864 | 3,218 | 48.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 23,056 |
| BeOne Medicines AG | 12,000 |
| 3SBio | 6,268 |
| Innovent Biologics | 6,190 |
| Shanghai Henlius Biotech | 3,537 |
| Akeso | 3,529 |
| RemeGen | 3,070 |
| Shanghai Junshi Biosciences | 2,670 |
WuXi Biologics News
- 4 days ago - WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture - PRNewsWire
- 5 days ago - WuXi Biologics Reports Record 2025 Annual Results - PRNewsWire
- 8 days ago - World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target - PRNewsWire
- 17 days ago - WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation - PRNewsWire
- 4 weeks ago - WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year - PRNewsWire
- 7 weeks ago - WuXi Biologics Awarded EcoVadis Platinum Medal for Third Consecutive Year, Ranking Among Top 1% Globally - PRNewsWire
- 2 months ago - WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody - PRNewsWire
- 2 months ago - HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline - PRNewsWire